News
Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.
News
Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.
NIH Strategizes to Streamline Gene Therapy Development
May 2, 2024 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
- Platform Vector Gene Therapy (PaVe-GT)
- Somatic Cell Genome Editing (SCGE)
P.J. Brooks, Ph.D., on Working to Bring Gene Therapy Development to More Neuromuscular Disorders
March 5, 2024 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
- Platform Vector Gene Therapy (PaVe-GT)
Propelling Cures With Genetics Research: Interview With Joni L. Rutter, PhD, Director of the National Center for Advancing Translational Sciences at NIH
December 14, 2023 - Grantee/Partner News
- 3-D Tissue Bioprinting
- Bespoke Gene Therapy Consortium (BGTC)
- Clinical and Translational Science Awards (CTSA) Program
- New Therapeutic Uses (NTU)
- Platform Vector Gene Therapy (PaVe-GT)
- Rare Diseases Clinical Research Network (RDCRN)
- Somatic Cell Genome Editing (SCGE)
- Therapeutics for Rare and Neglected Diseases (TRND)
- Tissue Chip for Drug Screening
Ex Vivo vs In Vivo Gene Therapy
February 2, 2023 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
‘I Thought I Had Woken Up to an Earthquake’: What We Heard This Week
January 22, 2023 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
NIH Project Aims to Make Gene Therapy ‘Playbook’ Public
January 18, 2023 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
As more families raise money for and partner with researchers to develop tailored, personalized treatments for rare diseases, some NIH agencies are trying to help by streamlining the process.
The Bespoke Gene Therapy Consortium
November 30, 2022 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)
Avrobio Receives Orphan Drug Designation for Hunter Syndrome Gene Therapy
July 14, 2022 - Media Coverage
- Bespoke Gene Therapy Consortium (BGTC)